Ipswich Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $526K | Hold |
4,165
| – | – | 0.11% | 124 |
|
|
2026
Q1 | $580K | Sell |
4,165
-185
| -4% | -$25.9K | 0.14% | 118 |
|
|
2025
Q4 | $534K | Sell |
4,350
-215
| -5% | -$26.1K | 0.12% | 118 |
|
|
2025
Q3 | $507K | Sell |
4,565
-100
| -2% | -$11.4K | 0.12% | 118 |
|
|
2025
Q2 | $517K | Hold |
4,665
| – | – | 0.12% | 121 |
|
|
2025
Q1 | $523K | Hold |
4,665
| – | – | 0.13% | 117 |
|
|
2024
Q4 | $431K | Hold |
4,665
| – | – | 0.1% | 128 |
|
|
2024
Q3 | $391K | Hold |
4,665
| – | – | 0.09% | 139 |
|
|
2024
Q2 | $320K | Sell |
4,665
-40
| -0.9% | -$2.67K | 0.07% | 154 |
|
|
2024
Q1 | $345K | Hold |
4,705
| – | – | 0.08% | 150 |
|
|
2023
Q4 | $381K | Sell |
4,705
-250
| -5% | -$19.5K | 0.1% | 136 |
|
|
2023
Q3 | $371K | Sell |
4,955
-250
| -5% | -$19.2K | 0.1% | 136 |
|
|
2023
Q2 | $401K | Sell |
5,205
-225
| -4% | -$17.9K | 0.11% | 136 |
|
|
2023
Q1 | $451K | Buy |
5,430
+60
| +1% | +$4.97K | 0.12% | 131 |
|
|
2022
Q4 | $461K | Buy |
5,370
+20
| +0.4% | +$1.58K | 0.13% | 129 |
|
|
2022
Q3 | $330K | Buy |
5,350
+255
| +5% | +$16.1K | 0.11% | 139 |
|
|
2022
Q2 | $315K | Hold |
5,095
| – | – | 0.09% | 148 |
|
|
2022
Q1 | $303K | Hold |
5,095
| – | – | 0.08% | 158 |
|
|
2021
Q4 | $370K | Sell |
5,095
-125
| -2% | -$8.61K | 0.09% | 157 |
|
|
2021
Q3 | $365K | Sell |
5,220
-280
| -5% | -$19.7K | 0.09% | 152 |
|
|
2021
Q2 | $379K | Hold |
5,500
| – | – | 0.1% | 152 |
|
|
2021
Q1 | $355K | Buy |
5,500
+1,000
| +22% | +$64.5K | 0.1% | 141 |
|
|
2020
Q4 | $262K | Sell |
4,500
-600
| -12% | -$36.2K | 0.08% | 156 |
|
|
2020
Q3 | $322K | Sell |
5,100
-55
| -1% | -$3.81K | 0.1% | 135 |
|
|
2020
Q2 | $397K | Sell |
5,155
-3,096
| -38% | -$237K | 0.14% | 118 |
|
|
2020
Q1 | $617K | Buy |
8,251
+100
| +1% | +$6.91K | 0.24% | 90 |
|
|
2019
Q4 | $530K | Sell |
8,151
-280
| -3% | -$18.2K | 0.16% | 119 |
|
|
2019
Q3 | $534K | Hold |
8,431
| – | – | 0.17% | 115 |
|
|
2019
Q2 | $570K | Sell |
8,431
-30
| -0.4% | -$1.97K | 0.18% | 112 |
|
|
2019
Q1 | $550K | Sell |
8,461
-50
| -0.6% | -$3.32K | 0.18% | 108 |
|
|
2018
Q4 | $532K | Sell |
8,511
-25
| -0.3% | -$1.75K | 0.2% | 97 |
|
|
2018
Q3 | $659K | Buy |
+8,536
| New | +$645K | 0.22% | 91 |
|
|
2018
Q2 | – | Sell |
-8,536
| Closed | -$644K | – | 111 |
|
|
2018
Q1 | $644K | Sell |
8,536
-30
| -0.4% | -$2.38K | 0.27% | 87 |
|
|
2017
Q4 | $614K | Buy |
8,566
+340
| +4% | +$25.8K | 0.26% | 87 |
|
|
2017
Q3 | $666K | Sell |
8,226
-300
| -4% | -$22.9K | 0.3% | 83 |
|
|
2017
Q2 | $603K | Sell |
8,526
-24,161
| -74% | -$1.61M | 0.28% | 81 |
|
|
2017
Q1 | $2.22M | Buy |
32,687
+2,331
| +8% | +$164K | 0.97% | 39 |
|
|
2016
Q4 | $2.17M | Buy |
30,356
+355
| +1% | +$26.4K | 0.98% | 38 |
|
|
2016
Q3 | $2.37M | Buy |
30,001
+816
| +3% | +$66.3K | 1.16% | 32 |
|
|
2016
Q2 | $2.44M | Sell |
29,185
-1,356
| -4% | -$120K | 1.2% | 34 |
|
|
2016
Q1 | $2.62M | Sell |
30,541
-3,514
| -10% | -$317K | 1.25% | 29 |
|
|
2015
Q4 | $3.45M | Buy |
34,055
+1,390
| +4% | +$145K | 1.55% | 21 |
|
|
2015
Q3 | $3.21M | Sell |
32,665
-395
| -1% | -$43.9K | 1.53% | 23 |
|
|
2015
Q2 | $3.87M | Sell |
33,060
-1,125
| -3% | -$123K | 1.74% | 18 |
|
|
2015
Q1 | $3.35M | Sell |
34,185
-900
| -3% | -$91.4K | 1.47% | 22 |
|
|
2014
Q4 | $3.31M | Sell |
35,085
-45
| -0.1% | -$4.65K | 1.41% | 28 |
|
|
2014
Q3 | $3.74M | Sell |
35,130
-110
| -0.3% | -$10.8K | 1.59% | 21 |
|
|
2014
Q2 | $2.92M | Buy |
35,240
+705
| +2% | +$54.9K | 1.13% | 36 |
|
|
2014
Q1 | $2.45M | Buy |
34,535
+24,085
| +230% | +$1.89M | 1.05% | 41 |
|
|
2013
Q4 | $785K | Buy |
10,450
+400
| +4% | +$27.9K | 0.33% | 66 |
|
|
2013
Q3 | $632K | Buy |
10,050
+350
| +4% | +$20.9K | 0.28% | 73 |
|
|
2013
Q2 | $498K | Buy |
+9,700
| New | +$506K | 0.21% | 89 |
|
Other funds holding GILD
Ipswich Investment Management's GILD Position: Q2 2026 in Review
Ipswich Investment Management held its Gilead Sciences (GILD) position steady in Q2 2026 at 4,165 shares worth $526K. The position accounts for 0.11% of the portfolio, ranked #124.
Ipswich Investment Management first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.87M in Q2 2015. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Ipswich Investment Management held 4,165 shares of Gilead Sciences worth $526K as of Q2 2026.
- Ipswich Investment Management left its Gilead Sciences share count unchanged in Q2 2026.
- Gilead Sciences made up 0.11% of Ipswich Investment Management's portfolio in Q2 2026, its #124 holding.
- Ipswich Investment Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Ipswich Investment Management's Gilead Sciences position peaked at $3.87M in Q2 2015.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Ipswich Investment Management's 13F filing for Q2 2026, filed 16 Jul 2026.